// App-Quantinova.ai

: Lower than recommended doses of cinacalcet are effective and well tolerated in the control of hypercalcaemia of primary hyperparathyroidism

Researchers

Presenter

  • Nyein Nge Nge

Principal Investigators

  • Mohamed Malik

Medical Centers

  • Hull University Teaching Hospital NHS Trust, General Internal Medicine, Hull, United Kingdom

  • Scunthorpe General Hospital, Endocrinology Department, Scunthorpe, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Primary hyperparathyroidism

  • Hypercalcaemia

Biomarkers

  • N/A

Drug/Treatment

  • Cinacalcet hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved